[1] Choi J,Han S,Kim N,et al.Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population.Hepatology,2017,66(5):1454-1463. [2] Kang Y,Cai Y.Gut microbiota and hepatitis-B-virus-induced chronic liver disease:implications for faecal microbiota transplantation therapy.J Hosp Infect,2017,96(4):342-348. [3] Boni C,Lampertico P,Talamona L,et al.Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.Hepatology,2015,62(6):1697-1709. [4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015更新版). 中华肝脏病杂志,2015,23(12):888-905. [5] Kang Y,Cai Y.Gut microbiota and hepatitis-B-virus-induced chronic liver disease:implications for faecal microbiota transplantation therapy. J Hosp Infect,2017,96(4):342-348. [6] Cheng X,Xia Y,Serti E,et al.Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology,2017,66(6):1779-1793. [7] Tan-Garcia A,Wai LE,Zheng D,et al.Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease. J Hepatol,2017,67(3):490-500. [8] Rong Y,Dong Z,Hong Z,et al.Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+T cell response and better prognosis in HBV-related hepatocellular carcinoma. Exp Cell Res,2017,358(2):352-359. [9] Gao WY,Li D,Cai DE,et al.Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore. Oncol Rep,2017,37(1):48-56. [10] Datta S,Roychoudhury S,Ghosh A,et al.Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients. PLoS One,2014,9(7):e102573. [11] Taida T,Arai M,Kanda T,et al.The prognosis of hepatitis B inactive carriers in Japan:a multicenter prospective study. J Gastroenterol,2017,52(1):113-122. [12] Lu HF,Wu ZW,Xu W,et al:Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Microb Ecol,2012,61(3):304-313. [13] Esmaeelzadeh A,Saadatnia H,Memar B,et al.Evaluation of serum HBV viral load,transaminases and histological features in chronic HBeAg-negative hepatitis B patients. Gastroenterol Hepatol Bed Bench,2017,10(1):39-43. [14] Xu L,Tu Z,Xu G,et al.Epirubicin directly promotes hepatitis B virus(HBV) replication in stable HBV-expressing cell lines:a novel mechanism of HBV reactivation following anticancer chemotherapy. Mol Med Rep,2014,9(4):1345-1350. [15] Suppiah J,Mohd Zain R,Bahari N,et al.G1896A precore mutation and association with HBeAg status,genotype and clinical status in patients with chronic hepatitis B. Hepat Mon,2015,15(10):e31490. [16] Balkan A,Namiduru M,Balkan Y,et al.Are serum quantitative hepatitis b surface antigen levels,liver histopathology and viral loads related in chronic hepatitis b-infected patients Saudi [J] Gastroenterol,2016,22(3):208-214. [17] Biazar T,Yahyapour Y,Hasanjani Roushan MR,et al.Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B. Caspian J Intern Med,2015,6(4):209-212. [18] 翟慧勤,范红,耿嘉蔚,等. 轻微型肝性脑病患者的肠道微生物群和血浆内毒素水平. 中华肝脏病杂志,2014,22(2):104-107. [19] 陈鸿杰,彭劼. 粪便菌群移植与慢性乙型肝炎. 实用肝脏病杂志,2017,20(6):658-659. [20] Zheng JS,Chen MM,Yang HF,et al.Stool vs. serum hepatitis B virus DNA in patients with chronic hepatitis B. Med Sci Monit,2015,9(21):3840-3486. |